These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2726619)
1. Selection of postmenopausal women for estrogen therapy. Christiansen C Postgrad Med; 1989 Apr; Spec No():10-2; discussion 33-43. PubMed ID: 2726619 [No Abstract] [Full Text] [Related]
2. Neutron activation studies and the effect of exercise on osteoporosis. Harrison JE J Med; 1984; 15(4):285-94. PubMed ID: 6597259 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of regional bone measurements in patients with osteoporotic fractures. Christiansen C; Riis B; Nilas L; Gotfredsen A Rev Med Brux; 1987; 8(6-7):311-6. PubMed ID: 3671921 [No Abstract] [Full Text] [Related]
4. Differential effects of thiazide and estrogen upon bone mineral content and fracture prevalence. Wasnich RD; Ross PD; Heilbrun LK; Vogel JM; Yano K; Benfante RJ Obstet Gynecol; 1986 Apr; 67(4):457-62. PubMed ID: 3960416 [TBL] [Abstract][Full Text] [Related]
5. [Postmenopausal osteoporosis. Early diagnosis as an indication for preventive hormone therapy]. Dören M; Montag M; Schneider HP Radiologe; 1988 Apr; 28(4):149-52. PubMed ID: 3380945 [TBL] [Abstract][Full Text] [Related]
6. Fracture frequency and bone preservation in postmenopausal women treated with estrogen. Jensen GF; Christiansen C; Transbøl I Obstet Gynecol; 1982 Oct; 60(4):493-6. PubMed ID: 7121935 [TBL] [Abstract][Full Text] [Related]
7. Present status of estrogen treatment for prevention of postmenopausal osteoporosis. Furuhjelm M; Zador G Acta Obstet Gynecol Scand Suppl; 1979; 88():97-101. PubMed ID: 294116 [No Abstract] [Full Text] [Related]
8. Effects of nandrolone therapy on forearm bone mineral content in osteoporosis. Need AG; Horowitz M; Morris HA; Walker CJ; Nordin BE Clin Orthop Relat Res; 1987 Dec; (225):273-8. PubMed ID: 3677513 [TBL] [Abstract][Full Text] [Related]
10. Non-invasive measurements of bone loss in peripheral bones. Meema HE Clin Invest Med; 1982; 5(2-3):157-60. PubMed ID: 7116720 [No Abstract] [Full Text] [Related]
13. [Sex hormone replacement following menopause--for all women? A plea for prevention using estrogens and gestagens]. Nocke W Ther Umsch; 1995 Oct; 52(10):693-704. PubMed ID: 7482382 [TBL] [Abstract][Full Text] [Related]
14. Thiazide diuretics and bone mineral content in postmenopausal women. Adland-Davenport P; McKenzie MW; Notelovitz M; McKenzie LC; Pendergast JF Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 1):630-4. PubMed ID: 4025422 [TBL] [Abstract][Full Text] [Related]
15. Influence of the menopause on ischaemic heart disease and its risk factors and on bone mineral content. Lindquist O Acta Obstet Gynecol Scand Suppl; 1982; 110():1-32. PubMed ID: 6957134 [TBL] [Abstract][Full Text] [Related]
16. Estrogen: prevention and treatment of osteoporosis. Lindsay R Postgrad Med; 1989 Apr; Spec No():7-9; discussion 33-43. PubMed ID: 2726631 [No Abstract] [Full Text] [Related]
17. Bone mineral screening for osteoporosis. Hall FM; Davis MA; Baran DT N Engl J Med; 1987 Jan; 316(4):212-4. PubMed ID: 3540669 [No Abstract] [Full Text] [Related]
18. Diagnosis and management of osteoporosis. With emphasis on postmenopausal women. Nordin BE; Need AG Aust Fam Physician; 1988 Mar; 17(3):170-3. PubMed ID: 3355435 [No Abstract] [Full Text] [Related]
19. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Lindsay R; Hart DM; Clark DM Obstet Gynecol; 1984 Jun; 63(6):759-63. PubMed ID: 6374537 [TBL] [Abstract][Full Text] [Related]